Testing effectiveness (Phase 2)Ended earlyNCT01031537
What this trial is testing
Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)
Who this might be right for
Tick-Borne EncephalitisEncephalitis, Tick-BorneTick-Borne Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 69